Immunoscintigraphy of Small-Cell Lung Cancer
Author Information
Author(s): C.H. Macmillan, A.C. Perkins, M.L. Wastie, I.H. Leach, D.A.L. Morgan
Primary Institution: Department of Clinical Oncology, General Hospital, Nottingham; Department of Medical Physics and Radiology, University Hospital, Nottingham; Department of Histopathology, City Hospital, Nottingham, UK.
Hypothesis
Can anti-carcinoembryonic antigen monoclonal antibodies effectively localize small-cell lung cancer in vivo?
Conclusion
The study demonstrated that anti-CEA monoclonal antibodies can localize within small-cell lung cancer deposits sufficiently for external imaging.
Supporting Evidence
- 62% of patients showed positive imaging for tumor localization.
- Positive uptake was observed at tumor sites in all three patients with elevated serum CEA levels.
- Eight out of 15 patients with normal serum CEA still had positive scans.
Takeaway
Doctors used special antibodies to take pictures of lung cancer in patients, and they found that these antibodies could help show where the cancer is.
Methodology
Immunoscintigraphy was performed on 21 patients using two types of radiolabelled anti-CEA monoclonal antibodies.
Potential Biases
Potential for false-positive results due to non-specific localization in inflammatory tissue.
Limitations
The study had a small sample size and did not compare the antibodies directly.
Participant Demographics
Patients included nine with newly diagnosed SCLC and twelve who had relapsed after treatment.
Want to read the original?
Access the complete publication on the publisher's website